ArticlePharmaceutical research2026
A Population-based Gastrointestinal Transit Model Using Individual-Level Imaging Data.
Article in Pharmaceutical research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeGastrointestinal (GI) transit is a key determinant of oral drug absorption. Existing GI transit models derived from summary transit-time distributions provide limited characterization of inter-individual variability. This study aimed to develop a population-based GI transit model using individual-level imaging data.
methodsIndividual gastric emptying (GE), small intestinal (SI) transit, and colon arrival (CA) data from imaging studies of non-absorbed markers in healthy adults were extracted from the literature. A population-based GI transit model was developed using sequential Weibull GE and transit compartment models. Formulation type and prandial state were evaluated as covariates, and inter-individual variability was estimated on key transit parameters.
resultsIndividual data comprising 90 GE, 26 SI, and 39 CA profiles were included. The final model consisted of a Weibull GE component and a six-compartment SI transit model. Formulation type and prandial state significantly influenced GE. Mean GE time was 0.16 h for liquid formulations under fasted conditions, while mean SI transit time was 2.97 h with substantial inter-individual variability (CV = 50.0%).
conclusionThis population-based GI transit model, informed by individual imaging data, quantitatively captures both mean transit behavior and inter-individual variability and may facilitate mechanistic absorption frameworks for oral drug exposure prediction.
Indexed as
Identifiers
42786367What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.